SWARTZ ROBIN (Chief Operating Officer) sold 2.7% of their position (3.09K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $15.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/15/2025ACC: 0001104659-25-003773
Officer· Chief Operating Officer
Since Feb 2022
-3.09K
Net shares
Net seller
$15.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.09K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.09K
Price / share
$5.09
Trade value
$15.71K
% of position
2.7%
1/14/2025
112.33K→109.24K
Total
Net shares
−3.09K
Net value
-$15.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2025 | S · Sale | −3.09K | $5.09 | $15.71K | 2.7% | 112.33K | 109.24K |
| Total | −3.09K | -$15.71K | ||||||
Derivative Transactions0
No derivative transactions reported